- Home
- FDMT vs EIKN Comparison
FDMT vs EIKN Comparison
Compare FDMT & EIKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FDMT | EIKN |
|---|---|---|
| Founded | 2013 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 695.3M | 631.0M |
| IPO Year | 2019 | 2026 |
Fundamental Metrics
Financial Performance| Metric | FDMT | EIKN |
|---|---|---|
| Price | $13.84 | $7.41 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 6 |
| Target Price | ★ $27.82 | $24.60 |
| AVG Volume (30 Days) | ★ 773.8K | 518.4K |
| Earning Date | 11-09-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.79 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $85,209,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $56.84 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 230194.60 | N/A |
| 52 Week Low | $6.96 | $7.55 |
| 52 Week High | $16.93 | $16.50 |
Technical Indicators
Market Signals| Indicator | FDMT | EIKN |
|---|---|---|
| Relative Strength Index (RSI) | 50.33 | 35.89 |
| Support Level | $13.39 | N/A |
| Resistance Level | $15.29 | $10.20 |
| Average True Range (ATR) | 0.88 | 0.64 |
| MACD | -0.12 | -0.09 |
| Stochastic Oscillator | 37.21 | 12.80 |
Price Performance
Historical ComparisonAbout FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).
About EIKN Eikon Therapeutics Inc. Common Stock
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.